DR Congo Receives First Doses of RVBO Ebola Vaccine

The Democratic Republic of Congo has received the initial batch of RVBO vaccines to combat Ebola, marking a crucial step in the nation's ongoing public health efforts. On Friday, August 21, 2026, Dr. Samuel Roger Kamba, the Minister of Public Health, Hygiene, and Social Welfare, oversaw the reception of 16,520 vaccine doses at N’djili International Airport in Kinshasa.

These vital vaccines were financed by Gavi, the Vaccine Alliance, and were manufactured in Germany. Before arriving in Kinshasa, the shipment transited through Switzerland, Luxembourg, and Belgium, underscoring the international collaboration involved in this health initiative. This first delivery is part of a larger consignment, with a total of 50,120 doses expected to arrive between August 21 and August 24, according to the Ministry of Health.

The arrival of the RVBO vaccine is a significant boost to the Congolese government's strategy to control and eradicate Ebola outbreaks. It aims to enhance the protection of populations most at risk, with continued support from international partners. The proactive procurement and distribution of vaccines are essential components of the national response plan, complementing existing surveillance and treatment measures.

This development highlights the persistent threat of Ebola in the region and the concerted efforts required to manage its impact. The timely arrival of these vaccines provides a much-needed tool for healthcare workers on the front lines, reinforcing the country's capacity to respond effectively to potential outbreaks and safeguard public health.